"Even when medicines are funded off the lists - the time taken to achieve an investment decision has doubled over the past 2 years. (Is now an average of 7.7 years, compared to 3.4 years in 2020)," says the new report. …
New report reveals blowout in wait times for funded access in NZ
April 27, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
The 'Dispatched' Week in Review' Podcast - 27 February
February 27, 2026 - - Podcast -
EU backs Australian-led consortium with up to $250m to advance next-generation influenza vaccines
February 26, 2026 - - Latest News -
United front forms across Asia Pacific to change the future of Pulmonary Arterial Hypertension
February 26, 2026 - - Latest News -
There are, in effect, two Pharmaceutical Benefits Schemes operating in Australia today
February 26, 2026 - - Latest News -
Reading the room on reform might mean following the Budget message
February 25, 2026 - - Latest News -
Weight-loss medicines approved in New Zealand, and recommended for funding, but pathway remains unclear
February 25, 2026 - -
Neurizon advances ALS drug program as funding, trials and global partnerships gain momentum
February 25, 2026 - - Australian Biotech